Characteristics, Cardiovascular Comorbidity and Medicines Management in Patients with Type 2 Diabetes and CKD: Results of the IRIDIEM Study

Publisher： Karger

E-ISSN： 1423-0143|33|2|119-128

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.33, Iss.2, 2010-04, pp. : 119-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comorbidity and Mortality in Peritoneal Dialysis: A Comparative Study of Type 1 and 2 Diabetes versus Nondiabetic Patients

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 290-296

Karger

Access to resources Recommend Favorite

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 136-145

Karger

Access to resources Recommend Favorite

Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics

By  

Kidney and Blood Pressure Research, Vol. 27, Iss. 4, 2004-09 ,pp. : 259-266

Karger

Access to resources Recommend Favorite

Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-05 ,pp. : 104-114

Karger

Access to resources Recommend Favorite

Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study

By  

Cardiorenal Medicine, Vol. 2, Iss. 1, 2011-10 ,pp. : 1-10

Karger

Access to resources Recommend Favorite